TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Science

• Publication date

  2004-02-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.1090922PMID 14764882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signal Transduction by the TGF-β Superfamily

  2002cited by this paper
• Signal transduction by the TGF-beta superfamily.

  2002cited by this paper
• Conditional inactivation of the TGF‐β type II receptor using Cre:Lox

  2002cited by this paper
• Evidence that fibroblasts derive from epithelium during tissue fibrosis.

  2002cited by this paper
• c-MYC: more than just a matter of life and death

  2002cited by this paper
• Scatter Factor/Hepatocyte Growth Factor Stimulation of Glioblastoma Cell Cycle Progression through G1 Is c-Myc Dependent and Independent of p27 Suppression, Cdk2 Activation, or E2F1-Dependent Transcription

  2002cited by this paper
• Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts.

  2001cited by this paper
• TGFbeta signaling in growth control, cancer, and heritable disorders.

  2000cited by this paper
• Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells.

  2000cited by this paper
• Generalized lacZ expression with the ROSA26 Cre reporter strain

  1999cited by this paper
• Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor

  1998cited by this paper
• Transforming growth factor-beta selectively inhibits branching morphogenesis but not tubulogenesis.

  1997cited by this paper
• Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.

  1997cited by this paper
• Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction.

  1996cited by this paper
• TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.

  1996cited by this paper
• Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction

  1995cited by this paper
• Identification and characterization of a fibroblast marker: FSP1

  1995cited by this paper
• Regulation of organogenesis. Common molecular mechanisms regulating the development of teeth and other organs.

  1995cited by this paper
• Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo.

  1991cited by this paper
• Mesenchyme-induced changes in the neoplastic characteristics of the Dunning prostatic adenocarcinoma.

  1991cited by this paper
• Binding of transforming growth factor-beta to cell surface proteins varies with cell type.

  1989cited by this paper
• Stromal-epithelial interactions in adult organs.

  1985cited by this paper
• NEOPLASMS: Malignant, Intrauterine transplantation of rat basal cell carcinoma as a model for reconversion of malignant to benign growth

  1978cited by this paper

• Local mechanobiological disruption in solid tumor-driven vascular permeability: a competition between mechanical vs chemical stimuli.

  2026cites this paper
• Signaling pathways and targeted interventions for precancers

  2026cites this paper
• Predicting Prognosis and Immunotherapy Response in Glioblastoma (GBM) With a 5‐Gene CAF‐Risk Signature

  2025cites this paper
• Nfil3 contributes to renal fibrosis by activating fibroblasts through directly promoting the expression of Spp1.

  2025cites this paper
• Prostatic Escherichia coli infection drives CCR2-dependent recruitment of fibrocytes and collagen production

  2025cites this paper
• KDM6A downregulation promotes tumor-prone cytokines expression in cancer-associated fibroblasts by activating enhancers

  2025cites this paper
• Oligomeric cystatin C supports the immunosuppressive activity of myeloid cells through interaction with inhibitory receptors

  2025cites this paper
• FSP1/S100A4-Expressing Stem/Progenitor Cells Are Essential for Temporomandibular Joint Growth and Homeostasis

  2025cites this paper
• TGF-β signaling in organoids: The mechanisms and applications in 3D

  2025cites this paper
• Cross-talk between cancer-associated fibroblasts and dormant cancer cells: current status and promising therapeutic potential

  2025cites this paper
• Cancer-Associated Fibroblasts Genes and Transforming Growth Factor Beta Pathway in Gastric Cancer for Novel Therapeutic Strategy

  2025cites this paper
• CAF-derived exosomal miR-196b-5p after androgen deprivation therapy promotes epithelial-mesenchymal transition in prostate cancer cells through HOXC8/NF-κB signaling pathway

  2025cites this paper
• TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma

  2025cites this paper
• Constructing Cell-Specific Causal Networks of Individual Cells for Depicting Dynamical Biological Processes

  2025cites this paper
• Stromal fibroblastic mutant Trp53 promotes mammary tumor development via enhanced secretion of paracrine factors

  2025cites this paper
• Potential of Fibulin2 as a therapeutic target against cancer and as a diagnostic marker (Review)

  2025cites this paper
• Radiation Reprograms Fibroblasts to Drive Prostate Cancer Therapy Resistance.

  2025cites this paper
• The Role of CAF‐derived Vitronectin in Promoting Colorectal Cancer Progression and Immunosuppression

  2025cites this paper
• PTPN11 in cartilage development, adult homeostasis, and diseases

  2025cites this paper
• Defining aging-associated factors that increase susceptibility to prostate cancer.

  2025cites this paper
• The Microenvironment in DCIS and Its Role in Disease Progression.

  2025cites this paper
• Mapping the murine TMJ glenoid fossa over development, homeostasis and in response to disease

  2025cites this paper
• S100A4/FSP1: A Prognostic Marker and a Promising Target for Antitumor Therapy

  2025cites this paper
• Activation of transforming growth factor beta 1 through integrin alpha V beta 6 and its molecular insights into cancer progression, and future directions.

  2025cites this paper
• Tumor suppressor genes in the tumor microenvironment

  2025cites this paper
• EGR4 transcriptionally upregulates GDF15 to promote gastric cancer metastasis

  2025cites this paper
• Fetal heart as a new local site for hematopoiesis and macrophage formation.

  2025cites this paper
• Low densities of immune cells indicate unfavourable overall survival in patients suffering from squamous cell carcinoma of the lung

  2024cites this paper
• Dynamic allostery drives autocrine and paracrine TGF-β signaling

  2024cites this paper
• Molecular insights into hybrid tumors: Exploring the heterogeneity in plexiform ameloblastoma.

  2024cites this paper
• Breast pericytes: a newly identified driver of tumor cell proliferation

  2024cites this paper
• Discovery of a Linked Constellation of Gene Expression Revealed by Local Editing of Fibroblasts in Tumors

  2024cites this paper
• Heterogeneous Cardiac-Derived and Neural Crest–Derived Aortic Smooth Muscle Cells Exhibit Similar Transcriptional Changes After TGFβ Signaling Disruption

  2024cites this paper
• FSP1 stem/progenitor cells are essential for TMJ growth and homeostasis

  2024cites this paper
• PTGES is involved in myofibroblast differentiation via HIF‐1α‐dependent glycolysis pathway

  2024cites this paper
• Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer

  2024cites this paper
• Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer

  2024cites this paper
• Diverse Landscape of Genetically Engineered Mouse Models: Genomic and Molecular Insights into Prostate Cancer.

  2024cites this paper
• Tumor-matched and unmatched cancer associated fibroblasts exhibit differential effect on proliferation and FMOD and MMP9 gene expression in head and neck squamous cell carcinoma cells when cocultured in spheroids

  2024cites this paper
• Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities

  2024cites this paper
• The role of stromal cells in epithelial–mesenchymal plasticity and its therapeutic potential

  2024cites this paper
• Pediatric Solid Cancers: Dissecting the Tumor Microenvironment to Improve the Results of Clinical Immunotherapy

  2024cites this paper
• An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer

  2024cites this paper
• An innovative strategy harnessing self-activating CAR-NK cells to mitigate TGF-β1-driven immune suppression.

  2024cites this paper
• A platform of functional studies of ESCC-associated gene mutations identifies the roles of TGFBR2 in ESCC progression and metastasis.

  2024cites this paper
• Application of Original Prostate Cancer Progression Model Interacting with Fibroblasts in Preclinical Research

  2024cites this paper
• TGF-β signaling in health, disease and therapeutics

  2024cites this paper
• Sprouty genes regulate activated fibroblasts in mammary epithelial development and breast cancer

  2024cites this paper
• Beyond genetics: driving cancer with the tumour microenvironment behind the wheel

  2024cites this paper
• Tumor-stroma contact ratio - a novel predictive factor for tumor response to chemoradiotherapy in locally advanced oropharyngeal cancer

  2024cites this paper
• Fibroblasts as Playmakers of Cancer Progression: Current Knowledge and Future Perspectives

  2023cites this paper
• ASPORIN: A root of the matter in tumors and their host environment.

  2023cites this paper
• Current landscape of miRNAs and TGF-β signaling in lung cancer progression and therapeutic targets.

  2023cites this paper
• Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer

  2023cites this paper
• Cancer-associated Fibroblasts in Neoadjuvant Setting for Solid Cancers.

  2023cites this paper
• Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma

  2023cites this paper
• Skin aging from the perspective of dermal fibroblasts: the interplay between the adaptation to the extracellular matrix microenvironment and cell autonomous processes

  2023cites this paper
• Radiation-associated secondary malignancies: a novel opportunity for applying immunotherapies

  2023cites this paper
• Correlation of NNMT and DKK1 Protein Expression With Clinicopathological Characteristics and Prognosis of Breast Cancer

  2023cites this paper
• Fibroblasts in cancer: Unity in heterogeneity.

  2023cites this paper
• Tumor angiogenesis in gastric cancer

  2023cites this paper
• Synergetic impact of combined navoximod with cisplatin mitigates chemo-immune resistance via blockading IDO1+ CAFs-secreted Kyn/AhR/IL-6 and pol ζ-prevented CIN in human oral squamous cell carcinoma.

  2023cites this paper
• Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia

  2023cites this paper
• Novel multivalent S100A8 inhibitory peptides attenuate tumor progression and metastasis by inhibiting the TLR4-dependent pathway

  2023cites this paper
• Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy

  2023cites this paper
• Conditional ablation of heparan sulfate expression in stromal fibroblasts promotes tumor growth in vivo

  2023cites this paper
• TGF‐β levels significantly increases in patients with stage III and IV breast cancer and can be explored as a target for tumour diagnosis and staging

  2023cites this paper
• Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma: opportunities and challenges

  2023cites this paper
• Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer

  2023cites this paper
• Activation of the Hedgehog signaling pathway leads to fibrosis in aortic valves

  2023cites this paper
• Activated fibroblasts in cancer: Perspectives and challenges.

  2023cites this paper
• Recent Developments in the Study of the Microenvironment of Cancer and Drug Delivery.

  2023cites this paper
• Lobe-specific responses of TRAMP mice dorsolateral prostate following celecoxib and nintedanib therapy

  2023cites this paper
• Single‐Cell Integration of BMD GWAS Results Prioritize Candidate Genes Influencing Age‐Related Bone Loss

  2023cites this paper
• One-Pot N -α-C(sp 3 )– H Bond Functionalisation Cascade for the Synthesis of Polysubstituted Imidazoles

  2023cites this paper
• Two microRNAs of plasma-derived small extracellular vesicles as biomarkers for metastatic non-small cell lung cancer

  2023cites this paper
• PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome

  2022cites this paper
• Fatty Acid Signaling Impacts Prostate Cancer Lineage Plasticity in an Autocrine and Paracrine Manner

  2022cites this paper
• Role of prostate stem cells and treatment strategies in benign prostate hyperplasia.

  2022cites this paper
• Inflammation-associated premetastatic niche formation

  2022cites this paper
• Time-extended exposure of gastric epithelial cells to secretome of Helicobacter pylori-activated fibroblasts induces reprogramming of gastric epithelium towards pre-cancerogenic and pro-invasive phenotype.

  2022cites this paper
• Transforming Growth Factor-Beta Orchestrates Tumour and Bystander Cells in B-Cell Non-Hodgkin Lymphoma

  2022cites this paper
• Comprehensive analysis of INHBA: A biomarker for anti-TGFβ treatment in head and neck cancer

  2022cites this paper
• Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis

  2022cites this paper
• Promoting the healing of infected diabetic wound by an anti-bacterial and nano-enzyme-containing hydrogel with inflammation-suppressing, ROS-scavenging, oxygen and nitric oxide-generating properties.

  2022cites this paper
• Fibrous stroma: Driver and passenger in cancer development

  2022cites this paper
• Bioinformatics Analysis Reveals Cell Cycle-Related Gene Upregulation in Ascending Aortic Tissues From Murine Models

  2022cites this paper
• The functional multipotency of transforming growth factor β signaling at the intersection of senescence and cancer

  2022cites this paper
• Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer

  2022cites this paper
• Studying Activated Fibroblast Phenotypes and Fibrosis-Linked Mechanosensing Using 3D Biomimetic Models.

  2022cites this paper
• Novel Techniques Targeting Fibroblasts after Ischemic Heart Injury

  2022cites this paper
• Neoadjuvant radiation influences the pseudocapsule in soft tissue sarcoma: A histopathologic and radiographic evaluation.

  2022cites this paper
• Decrypting a path based approach for identifying the interplay between PI3K and GSK3 signaling cascade from the perspective of cancer

  2022cites this paper
• OVERCOMING TGF-  -MEDIATED IMMUNE EVASION

  2022cites this paper
• TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective

  2022cites this paper
• Loss of Dok-3 in Non-tumor Cells Induces Malignant Transformation of Benign Epithelial Tumor Cells of the Intestine

  2022cites this paper
• Tumor microenvironment: barrier or opportunity towards effective cancer therapy

  2022cites this paper
• Bioactive glass-based fibrous wound dressings

  2022cites this paper
• Therapeutic implications of the tumor microenvironment in ovarian cancer patients receiving PD-1/PD-L1 therapy

  2022cites this paper
• Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction

  2022cites this paper